000 01220 a2200349 4500
005 20250516110312.0
264 0 _c20130509
008 201305s 0 0 ger d
022 _a1435-1250
024 7 _a10.1007/s00393-012-1022-8
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSchmalzing, M
245 0 0 _a[Mycophenolate mofetil seems to be superior to azothioprine in maintenance therapy of lupus nephritis].
_h[electronic resource]
260 _bZeitschrift fur Rheumatologie
_cNov 2012
300 _a813-5 p.
_bdigital
500 _aPublication Type: Journal Article; Randomized Controlled Trial
650 0 4 _aAdult
650 0 4 _aAzathioprine
_xtherapeutic use
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aImmunosuppressive Agents
_xtherapeutic use
650 0 4 _aLupus Nephritis
_xdiagnosis
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aMycophenolic Acid
_xanalogs & derivatives
650 0 4 _aPlacebo Effect
650 0 4 _aTreatment Outcome
650 0 4 _aYoung Adult
700 1 _aKötter, I
773 0 _tZeitschrift fur Rheumatologie
_gvol. 71
_gno. 9
_gp. 813-5
856 4 0 _uhttps://doi.org/10.1007/s00393-012-1022-8
_zAvailable from publisher's website
999 _c22056335
_d22056335